GENESIS Pharma is a regional biopharma commercialization company established in Athens Greece in 1997. With more than 28 yrs expertise in launching and commercializing innovative biopharma products targeting severe and rare diseases in South East & Central Eastern Europe (CEE) we are looking for partners with late-stage assets to collaborate with. We are currently commercializing one or more assets from ALNYLAM, AMICUS, BIOGEN (who has been our partner since 1997), CSL VIFOR, DECIPHERA (now part of ONO), INCYTE, PHARMAMAR, SANTHERA, REGENERON, JAZZ Pharma, KRYSTAL BIO KYOWA KIRIN and OTSUKA. We cover all EU and Non-EU countries in the CEE including: Greece, Cyprus, Malta, Romania, Bulgaria, Slovenia, Croatia, Poland, Czech Republic, Hungary, Slovakia, Lithuania, Latvia, Estonia, Serbia, North Macedonia, Bosnia & Herzegovina, Montenegro, Albania, and Kosovo. For more info please refer to https://www.genesispharma.com/